T1	Participants 104 142	advanced upper gastrointestinal cancer
T2	Participants 220 278	patients with upper gastrointestinal adenocarcinoma (UGIA)
T3	Participants 291 332	Seventy-three patients with advanced UGIA
T4	Participants 847 889	Patients with normal levels, except CA72-4
T5	Participants 1349 1394	patients with UGIA on palliative chemotherapy
